The combination of metformin with morin alleviates hepatic steatosis via modulating hepatic lipid metabolism, hepatic inflammation, brown adipose tissue …

SS Tehrani, G Goodarzi, G Panahi, F Zamani-Garmsiri… - Life Sciences, 2023 - Elsevier
Aim The valuable effects of metformin (MET) and morin (MOR) in the improvement of NAFLD
have been proposed, nevertheless, their combination impacts were not investigated so far …

[HTML][HTML] Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity

SL Woo, H Xu, H Li, Y Zhao, X Hu, J Zhao, X Guo… - PloS one, 2014 - journals.plos.org
Non-alcoholic fatty liver disease (NAFLD) is closely associated with obesity and insulin
resistance. To better understand the pathophysiology of obesity-associated NAFLD, the …

Combination therapy of metformin and p-coumaric acid mitigates metabolic dysfunction associated with obesity and nonalcoholic fatty liver disease in high-fat diet …

G Goodarzi, SS Tehrani, G Panahi… - The Journal of …, 2023 - Elsevier
Metformin (MET) has been demonstrated to have favorable impact on nonalcoholic fatty liver
disease (NAFLD); however, the combined effect of this drug with p-coumaric acid (PCA) on …

Combination of metformin and genistein alleviates non-alcoholic fatty liver disease in high-fat diet-fed mice

F Zamani-Garmsiri, SMR Hashemnia… - The Journal of nutritional …, 2021 - Elsevier
Metformin (MET) and genistein (GEN) have a beneficial role in alleviating non-alcoholic fatty
liver disease (NAFLD), but their combined effect on this disease has not yet been studied …

Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high‐fat diet fed mice

F Zamani‐Garmsiri, G Ghasempour, M Aliabadi… - IUBMB …, 2021 - Wiley Online Library
Non‐alcoholic fatty liver disease (NAFLD) has become an important health problem in the
world. Natural products, with anti‐inflammatory properties, are potential candidates for …

[HTML][HTML] Metformin treatment reverses high fat diet-induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti …

T Yasmin, MM Rahman, F Khan, F Kabir… - … and Biophysics Reports, 2021 - Elsevier
Purpose This current study investigated the effect of metformin treatment on hepatic
oxidative stress and inflammation associated with nonalcoholic fatty liver disease (NADLD) …

Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice

K Tajima, A Nakamura, J Shirakawa… - American Journal …, 2013 - journals.physiology.org
The prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis
(NASH) is increasing with the growing epidemics of obesity and diabetes. NAFLD …

Interaction between metformin and leucine in reducing hyperlipidemia and hepatic lipid accumulation in diet-induced obese mice

L Fu, A Bruckbauer, F Li, Q Cao, X Cui, R Wu, H Shi… - Metabolism, 2015 - Elsevier
Abstract Background Leucine stimulates Sirt1 and AMPK signaling in vitro and in vivo. Since
metformin converges on the same pathway, we have tested the ability of leucine to amplify …

[HTML][HTML] Metformin ameliorates hepatic steatosis and improves the induction of autophagy in HFD‑induced obese mice

M Li, A Sharma, C Yin, X Tan… - Molecular medicine …, 2017 - spandidos-publications.com
The present study aimed to investigate the effect of metformin on the induction of autophagy
in the liver and adipose tissues of a mouse model of obesity. C57BL/6J mice were fed a high …

Morin attenuates hepatic insulin resistance in high-fat-diet-induced obese mice

J Naowaboot, S Wannasiri, P Pannangpetch - Journal of physiology and …, 2016 - Springer
Morin is a natural bioflavonoid that exhibits antioxidant and anti-inflammatory properties.
The present study was designed to evaluate the effect of morin on insulin resistance …